EQNUX
Price
$21.65
Change
+$0.01 (+0.05%)
Updated
Jun 5 closing price
Net Assets
623.1M
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.31B
Interact to see
Advertisement

EQNUX vs RMEBX

Header iconEQNUX vs RMEBX Comparison
Open Charts EQNUX vs RMEBXBanner chart's image
MFS Equity Income R4
Price$21.65
Change+$0.01 (+0.05%)
VolumeN/A
Net Assets623.1M
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.31B
EQNUX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EQNUX vs. RMEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQNUX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. EQNUX (623M). EQNUX pays higher dividends than RMEBX: EQNUX (2.26) vs RMEBX (1.16). EQNUX was incepted earlier than RMEBX: EQNUX (13 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than EQNUX (0.70). EQNUX is a more actively managed with annual turnover of: 45.00 vs. RMEBX (31.00). EQNUX has a lower initial minimum investment than RMEBX: EQNUX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. EQNUX (3.08). EQNUX return over 5 years is better than : 55.97 vs. RMEBX (49.85).
EQNUXRMEBXEQNUX / RMEBX
Total Expense Ratio0.641.0760%
Annual Report Gross Expense Ratio0.701.0765%
Fund Existence13 years11 years-
Gain YTD3.6355.34968%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets623M105B1%
Annual Yield % from dividends2.261.16195%
Returns for 1 year3.088.3037%
Returns for 3 years21.0617.96117%
Returns for 5 years55.9749.85112%
Returns for 10 years97.4968.21143%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA